(Q30867306)

27 June 2017

1 reference

title

Doxapram versus methylxanthine for apnea in preterm infants (English)

1 reference

27 June 2017

0 references

D J Henderson-Smart

1

1 reference

27 June 2017

P Steer

series ordinal

2

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

2000

0 references

published in

1 reference

27 June 2017

CD000075

1 reference

27 June 2017

2

1 reference

A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity.

27 June 2017

4

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000075

Second-degree atrioventricular heart block after doxapram administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000075

Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000075

Doxapram treatment for apnea in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000075

Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000075

10.1002/14651858.CD000075

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference